186 related articles for article (PubMed ID: 14659121)
1. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
Claus EB; Stowe M; Carter D; Holford T
Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121
[TBL] [Abstract][Full Text] [Related]
2. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
3. Risk of contralateral breast cancer among women with carcinoma in situ of the breast.
Habel LA; Moe RE; Daling JR; Holte S; Rossing MA; Weiss NS
Ann Surg; 1997 Jan; 225(1):69-75. PubMed ID: 8998122
[TBL] [Abstract][Full Text] [Related]
4. Population-Based Analysis of Breast Cancer Incidence and Survival Outcomes in Women Diagnosed with Lobular Carcinoma In Situ.
Wong SM; King T; Boileau JF; Barry WT; Golshan M
Ann Surg Oncol; 2017 Sep; 24(9):2509-2517. PubMed ID: 28455673
[TBL] [Abstract][Full Text] [Related]
5. Breast carcinoma in situ: risk factors and screening patterns.
Claus EB; Stowe M; Carter D
J Natl Cancer Inst; 2001 Dec; 93(23):1811-7. PubMed ID: 11734598
[TBL] [Abstract][Full Text] [Related]
6. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
Li CI; Daling JR; Malone KE
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
[TBL] [Abstract][Full Text] [Related]
7. The Pathologic Finding of Combined Lobular Carcinoma
Jean-Louis CJ; Masdon J; Smith B; Battles O; Dale P
Am Surg; 2017 May; 83(5):482-485. PubMed ID: 28541858
[TBL] [Abstract][Full Text] [Related]
8. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast.
Innos K; Horn-Ross PL
Breast Cancer Res Treat; 2008 Oct; 111(3):531-40. PubMed ID: 17978879
[TBL] [Abstract][Full Text] [Related]
9. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk.
Fowble B; Hanlon A; Freedman G; Nicolaou N; Anderson P
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):679-90. PubMed ID: 11597809
[TBL] [Abstract][Full Text] [Related]
10. Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.
Mullooly M; Khodr ZG; Dallal CM; Nyante SJ; Sherman ME; Falk R; Liao LM; Love J; Brinton LA; Gierach GL
Am J Epidemiol; 2017 Dec; 186(12):1329-1340. PubMed ID: 28637226
[TBL] [Abstract][Full Text] [Related]
11. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
Gapstur SM; Morrow M; Sellers TA
JAMA; 1999 Jun; 281(22):2091-7. PubMed ID: 10367819
[TBL] [Abstract][Full Text] [Related]
12. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
13. Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation.
Hill-Kayser CE; Harris EE; Hwang WT; Solin LJ
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1313-9. PubMed ID: 16997501
[TBL] [Abstract][Full Text] [Related]
14. A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States).
Cook LS; White E; Schwartz SM; McKnight B; Daling JR; Weiss NS
Cancer Causes Control; 1996 May; 7(3):382-90. PubMed ID: 8734833
[TBL] [Abstract][Full Text] [Related]
15. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
Ji J; Hemminki K
Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
[TBL] [Abstract][Full Text] [Related]
16. Family history of breast and ovarian cancer and the risk of breast carcinoma in situ.
Claus EB; Stowe M; Carter D
Breast Cancer Res Treat; 2003 Mar; 78(1):7-15. PubMed ID: 12611452
[TBL] [Abstract][Full Text] [Related]
17. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study.
Ottesen GL; Graversen HP; Blichert-Toft M; Christensen IJ; Andersen JA
Breast Cancer Res Treat; 2000 Aug; 62(3):197-210. PubMed ID: 11072784
[TBL] [Abstract][Full Text] [Related]
18. Mammographic density and risk of second breast cancer after ductal carcinoma in situ.
Habel LA; Capra AM; Achacoso NS; Janga A; Acton L; Puligandla B; Quesenberry CP
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2488-95. PubMed ID: 20929881
[TBL] [Abstract][Full Text] [Related]
19. The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study.
Elshof LE; Schaapveld M; Rutgers EJ; Schmidt MK; de Munck L; van Leeuwen FE; Wesseling J
Breast Cancer Res; 2017 Mar; 19(1):26. PubMed ID: 28274272
[TBL] [Abstract][Full Text] [Related]
20. Contralateral breast cancer: incidence according to ductal or lobular phenotype of the primary.
Langlands F; White J; Kearins O; Cheung S; Burns R; Horgan K; Sharma N; Dodwell D
Clin Radiol; 2016 Feb; 71(2):159-63. PubMed ID: 26703116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
